SPDR Barclays 3-12 Month T-Bill ETF (BILS)

$BILS $SPX $SPY $VOO this is the signal that I foolishly neglected to put weight on. Sometimes you don’t listen to yourself.

$BILS $DIA $IWM $QQQ $SPY hmmm… 🤔 this might be my go to indicator moving forward.

Not much BUT first time, since early April, that we're seeing a rise in the accumulation/distribution of $BILS which indicates potential increase in cash positions with 3-12 month T-Bills. How do you build cash? Selling, of course. Exactly what's being sold is hard to pinpoint but it's something to keep an eye on, at these astronomical highs. $SPY $QQQ $DIA $IWM

$SPY $QQQ I know the volume has been in focus lately BUT when we look at the accumulation/distribution of $BILS the 3-12 month T-Bills, we can't ignore the big drop. Why? This is dry powder moving from the sidelines and, obviously, into the markets. So, volume hasn't been painting the entire picture. The drop in the AD of $BILS started a few days before the March 30 bottom. This rally could go on a little longer but I'm still very skeptical and not chasing.

I'm not saying that we have bottomed. However, here is something to consider, given how overextended to the downside we are, for now. The 3-12 month T-Bill ETF $BILS could, relibly, be a gauge for institutional cash. When $SPX $SPY $VOO was in distribution and dumping, we saw accumulation. The interesting this, however, is that $BILS has a nascent distribution. Where this cash could be going is anyone's guess BUT there is historical precedent to distribution in this ETF signaling potential capital flowing back into equities. For now, if we start to bottom here, it is likely a dead cat bounce. Just something to consider and not any bold prediction on my end.

$BILS RSI: 100.00, MACD: 0.0870 Vol: 0.07, MA20: 99.23, MA50: 99.03 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

$BILS RSI: 100.00, MACD: 0.1024 Vol: 0.08, MA20: 99.29, MA50: 99.05 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

$BILS RSI: 100.00, MACD: 0.1163 Vol: 0.10, MA20: 99.01, MA50: 98.77 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

$SCNX [Again] Two (2) FDA approved drugs targeting unique/distinct markets totaling nearly $500M in domestic (US), annualized sales. Arbli was launched mid-August and already showed a $5M annualized run rate prior to scaling across national formularies. Exclusive IP protection thru 2041. Just a 15% penetration rate equates to $40-50M annualized revenue against a market cap of $25M. Separately-Rezenopy is scheduled to launch in Q1-2026 into a domestic market (narcan) measured in $BILS, though specific nasal spray retail approximates $150-200M. Another 15% penetration rate here implies $20-30M annualized revenue, accretive to Arbli. $40-60M revenue, multiple additional drugs under consideration in pipeline, experienced management launching novel pharma products, established production and marketing agreements. More than $8.0M in liquidity (equity placements) against debt that has largely been converted with $2.28 strike (appx). Multiplier upside (IMO) https://finance.yahoo.com/news/updated-lineup-announced-iaccess-alphas-140000061.html

$PTHRF $BILS